Damian Wild

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal. The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media. More information is on the Reasons to publish page.

Damian Wild Damian Wild Managing Director of ING Media Published Jun 29, 2023 I first interviewed Jonathan Symonds 20 years ago. Then the CFO of Astra Zeneca (him not me) I was struck by his combination of (checks notes) “a razor sharp mind and an ability to keep his feet on the ground”. No wonder a FTSE100 peer described him as “one of the best finance directors of his generation”.

Abstract : Simple Summary Patients with low- and intermediate-grade neuroendocrine tumors (NETs) of the lung, also called typical (TC) and atypical carcinoids (AC), are often managed in a very heterogenous way. This lack of standardized procedures, probably due to the rare occurrence of these tumors, was and is unfavorable for the affected patients. In 2015, the European NET society (ENETS) published new guidelines for best practice for TC and AC.